Four days after the mice were injected s.c. with NT-2 cells, they received the initial vaccination and by day 64 post tumor inoculation, there was approximately a 70% reduction in tumor size in treatment groups vaccinated with two of the VEGFR2 constructs. The gene discussed is KDR; the disease is neoplasm.